Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02436408
Title VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Acronym VISORB
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.